With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has also becomie the meeting point in Europe for tech transfer and sourcing early-stage innovations from public research institutions, academic spin-offs, and emerging biotech companies. Together with big pharma, biotech and diagnostics companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the marketplace for seed and Series A investment in Life Sciences. The conference features one-on-one meetings, presentation sessions, roundtable discussions, and exhibition floor.

KEY FIGURES:

* 1,000+ delegates

* 30 countries represented

* 2,700 one-to-one meetings scheduled

* 1,000 licensing opportunities